Clinical trial
MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and…
NCT00262119 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00262119 |
|---|---|
| Title | MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure |
| Official title | MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Heart Failure, Congestive |
| Intervention type | Device |
| Interventions | Pacemaker Medtronic EnRhythm |
| Enrollment | 1,300 |
| Start date | Feb 1, 2006 |
| Primary completion | Apr 1, 2012 |
| Completion | Apr 1, 2013 |
| First posted | Dec 6, 2005 |
| Last update posted | Jul 2, 2025 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: